Literature DB >> 25250281

Changing trends in characteristics of infantile hydronephrosis.

Azar Nickavar1, Seyyed Javad Nasiri2, Arash Lahouti Harahdashti3.   

Abstract

BACKGROUND: Hydronephrosis (HN) or calycial dilatation is the most common prenatal urologic abnormality. The aim of this study was to identify the possible changes in demographic and clinical manifestations of infantile HN in previously and recently diagnosed patients.
METHODS: 193 children with infantile HN admitted to Ali-asghar Children's Hospital in two different periods (group 1; 1997-2003, and group 2; 2005-2011) were evaluated in this cross-sectional study. Variables such as time at diagnosis, gender, clinical manifestations, etiology, laterality, grade, and associated anomalies were also evaluated.
RESULTS: The mean age at diagnosis was 32.3± 42.6 (group 1) and 21.4± 36.4 (group 2), respectively. 69.8% of patients were males. 75% of prenatally diagnosed patients were asymptomatic. Urinary tract infection was the most common symptom, followed by pain, hematuria, and decreased renal function. Obstruction in ureteropelvic junction was the most common etiology, accounting for 39.6% of all patients. Neurogenic bladder, vesicoureteral reflux, nephrolithiasis, and ureterovesical junction obstruction were the other common etiologies. 55.5% of all patients had unilateral HN, which was more common on the left side. No significant difference documented between two groups of patients, except for mild HN (23.7% vs. 39%), which was more common in newly diagnosed patients (p= 0.001).
CONCLUSION: There was no changing trend in demographic and clinical manifestations of infantile HN. However, the severity of infantile HN has been decreased significantly in recently diagnosed patients.

Entities:  

Keywords:  Children; Epidemiology; Hydronephrosis

Year:  2014        PMID: 25250281      PMCID: PMC4153476     

Source DB:  PubMed          Journal:  Med J Islam Repub Iran        ISSN: 1016-1430


  10 in total

1.  Intermittent hydronephrosis secondary to ureteropelvic junction obstruction: clinical and imaging features.

Authors:  Jeng-Daw Tsai; Fu-Yuan Huang; Chun-Chen Lin; Tsuen-Chiuan Tsai; Hung-Chang Lee; Jin-Cherng Sheu; Pei-Yeh Chang
Journal:  Pediatrics       Date:  2006-01       Impact factor: 7.124

2.  Causes of hydronephrosis in pyelonephritic children.

Authors:  Hadi Sorkhi
Journal:  Indian J Pediatr       Date:  2005-12       Impact factor: 1.967

Review 3.  Outcome of isolated antenatal hydronephrosis: a systematic review and meta-analysis.

Authors:  Gagan Sidhu; Joseph Beyene; Norman D Rosenblum
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

4.  Prenatal diagnosis of hydronephrosis: impact on renal function and its recovery after pyeloplasty.

Authors:  G Capolicchio; M P Leonard; C Wong; R Jednak; A Brzezinski; J L Salle
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

5.  Pediatric pyeloplasty: outcome analysis based on patient age and surgical technique.

Authors:  R W Sutherland; S K Chung; D R Roth; E T Gonzales
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

6.  Causes and outcome of prenatally diagnosed hydronephrosis.

Authors:  Ali Ahmadzadeh; Morteza Tahmasebi; Mohammad Momen Gharibvand
Journal:  Saudi J Kidney Dis Transpl       Date:  2009-03

Review 7.  Assessment and management of newborn hydronephrosis.

Authors:  Marcus Riccabona
Journal:  World J Urol       Date:  2004-06-12       Impact factor: 4.226

8.  Congenital hydronephrosis: prenatal diagnosis and epidemiology in Europe.

Authors:  Ester Garne; Maria Loane; Diana Wellesley; Ingeborg Barisic
Journal:  J Pediatr Urol       Date:  2008-11-05       Impact factor: 1.830

9.  Clinical outcome and follow-up of prenatal hydronephrosis.

Authors:  Afshin Safaei Asl; Shohreh Maleknejad
Journal:  Saudi J Kidney Dis Transpl       Date:  2012-05

10.  Prenatally detected ureteropelvic junction obstruction: clinical features and associated urologic abnormalities.

Authors:  Ibrahim Karnak; Lynn L Woo; Shetal N Shah; Arlene Sirajuddin; Robert Kay; Jonathan H Ross
Journal:  Pediatr Surg Int       Date:  2008-02-07       Impact factor: 1.827

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.